Hiroshi Kakeya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Kakeya has a total of 446 co-authors. Here are the top co-authors by number of shared publications:
Koichi Yamada
Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine
35 shared publicationsYukihiro Kaneko
Osaka International Research for Infectious Diseases (OIRCID), Osaka Metropolitan University
22 shared publicationsMakoto Niki
21 shared publicationsWataru Shibata
Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine
21 shared publications- Waki Imoto
Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine
20 shared publications Waki Imoto
18 shared publications
Latest Publications
- 9 November 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
A rare case of empyema caused by Streptococcus agalactiae serotype V
- 9 November 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
A rare case of empyema caused by Streptococcus agalactiae serotype V
- 11 April 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (6) , 102962
Impact of introducing nucleic acid amplification testing for diagnosing Clostridioides difficile infection at a Japanese university hospital
- 11 April 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (6) , 102962
Impact of introducing nucleic acid amplification testing for diagnosing Clostridioides difficile infection at a Japanese university hospital
- 28 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (4) , 102939
Diagnostic value of repeat deep sampling and cytocentrifugation in disseminated nocardiosis due to Nocardia brasiliensis with intramuscular and prostatic abscesses in a patient with myelodysplastic syndrome
- 28 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (4) , 102939
Diagnostic value of repeat deep sampling and cytocentrifugation in disseminated nocardiosis due to Nocardia brasiliensis with intramuscular and prostatic abscesses in a patient with myelodysplastic syndrome
- 16 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (4) , 102932
Comparison of baloxavir/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan
- 16 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (4) , 102932
Comparison of baloxavir/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan
- Open Access
- 31 July 2025
- Published by The Japanese Society for Medical Mycology in Medical Mycology Journal
- Vol. 66 (3) , 105-112
Development of an In Vitro Electrical Impedance Model to Assess Cytotoxicity and Antifungal Efficacy of Aspergillus fumigatus
Aspergillus fumigatus causes fatal infections in immunocompromised individuals, with the increasing number of azole-resistant strains leading to high mortality rates. This study aimed to develop a novel in vitro model using electrical impedance to continuously evaluate interactions between A. fumigatus and human cells and antifungal agent efficacy. A. fumigatus conidia and human cell lines (THP-1 macrophages and A549 alveolar epithelial cells) were cultured. Electrical impedance and fluorescence were observed using the xCELLigence RTCA E-Sight system. Conidia were seeded at various multiplicity of infection (MOI) values, and cell damage was assessed. In addition, the inhibition of cell damage by A. fumigatus in response to antifungal agents was evaluated. The time needed for electrical impedance to fall by half in macrophages was 31.5 hours for MOI 0.1 and 14.1 hours for MOI 8. Therefore, higher conidial concentrations led to faster decreases in electric impedance, indicating increased cytotoxicity. Macrophages showed a gradual decrease in electric impedance with mycelial growth, whereas A549 cells displayed a rapid electric impedance decline after mycelial growth. Azoles and amphotericin B suppressed the electric impedance decrease above their minimum inhibitory concentration, while echinocandins resulted in a continuous electric impedance decrease regardless of concentration. This study demonstrated that electrical impedance constitutes an objective method for continuously evaluating the cytotoxicity of A. fumigatus and antifungal efficacy. This novel in vitro model offers a new standard for studying interactions between filamentous fungi and human cells. Further validation using clinical isolates and other fungi is required.
- 31 July 2025
- Published by The Japanese Society for Medical Mycology in Medical Mycology Journal
- Vol. 66 (3) , 105-112
Open AccessDevelopment of an In Vitro Electrical Impedance Model to Assess Cytotoxicity and Antifungal Efficacy of Aspergillus fumigatus
Aspergillus fumigatus causes fatal infections in immunocompromised individuals, with the increasing number of azole-resistant strains leading to high mortality rates. This study aimed to develop a novel in vitro model using electrical impedance to continuously evaluate interactions between A. fumigatus and human cells and antifungal agent efficacy. A. fumigatus conidia and human cell lines (THP-1 macrophages and A549 alveolar epithelial cells) were cultured. Electrical impedance and fluorescence were observed using the xCELLigence RTCA E-Sight system. Conidia were seeded at various multiplicity of infection (MOI) values, and cell damage was assessed. In addition, the inhibition of cell damage by A. fumigatus in response to antifungal agents was evaluated. The time needed for electrical impedance to fall by half in macrophages was 31.5 hours for MOI 0.1 and 14.1 hours for MOI 8. Therefore, higher conidial concentrations led to faster decreases in electric impedance, indicating increased cytotoxicity. Macrophages showed a gradual decrease in electric impedance with mycelial growth, whereas A549 cells displayed a rapid electric impedance decline after mycelial growth. Azoles and amphotericin B suppressed the electric impedance decrease above their minimum inhibitory concentration, while echinocandins resulted in a continuous electric impedance decrease regardless of concentration. This study demonstrated that electrical impedance constitutes an objective method for continuously evaluating the cytotoxicity of A. fumigatus and antifungal efficacy. This novel in vitro model offers a new standard for studying interactions between filamentous fungi and human cells. Further validation using clinical isolates and other fungi is required.
- Open Access
- 24 May 2025
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 48 (5) , 694-705
Prospective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels
Voriconazole (VRCZ), an azole-based, deep-seated antifungal agent, is used as a 1st-line treatment for aspergillosis in Japan. VRCZ exhibits nonlinear pharmacokinetic (PK) behavior with relatively large inter-individual variability in plasma concentration. Additionally, genetic polymorphisms of CYP2C19 have been reported to influence the metabolic variability of VRCZ. The purpose of this study was to search for and identify clinically relevant potential factors influencing the PK and plasma concentration of VRCZ to better inform VRCZ dosing regimens. Thirty patients receiving VRCZ were enrolled. Total (Ct) and unbound (Cu) trough plasma concentrations of VRCZ were determined by the HPLC-UV method. Univariate and multivariate correlation analyses were used to evaluate the relationships between Ct or Ct/dose per body weight (Ct/D) and individual demographic and laboratory characteristics. Since the increasing trend of C-reactive protein (CRP) inversely correlated with the classification of CYP2C19 gene polymorphisms, it was suggested that the inflammation counteracted the trend of Ct according to CYP2C19 gene polymorphisms. Spearman’s rank-order correlation analysis showed significant correlations between Ct and dose per body weight, CRP, and α1-acid glycoprotein (α1-AGP). Multivariate linear regression analysis showed that age, dose per body weight, CRP, and α1-AGP were significant explanatory factors for Ct. In particular, elevated α1-AGP levels were found to have significant explanatory value for decreased Ct. Although the present study has critical limitations, such as the patient sample was small in size and being limited to a single medical institution, this finding may explain some of the inter-individual variability in plasma VRCZ concentration.
- 24 May 2025
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 48 (5) , 694-705
Open AccessProspective Analysis of Factors Influencing Inter-Individual Variation in Trough Plasma Voriconazole Concentrations in Older Patients—Impact of High α1-Acid Glycoprotein Levels
Voriconazole (VRCZ), an azole-based, deep-seated antifungal agent, is used as a 1st-line treatment for aspergillosis in Japan. VRCZ exhibits nonlinear pharmacokinetic (PK) behavior with relatively large inter-individual variability in plasma concentration. Additionally, genetic polymorphisms of CYP2C19 have been reported to influence the metabolic variability of VRCZ. The purpose of this study was to search for and identify clinically relevant potential factors influencing the PK and plasma concentration of VRCZ to better inform VRCZ dosing regimens. Thirty patients receiving VRCZ were enrolled. Total (Ct) and unbound (Cu) trough plasma concentrations of VRCZ were determined by the HPLC-UV method. Univariate and multivariate correlation analyses were used to evaluate the relationships between Ct or Ct/dose per body weight (Ct/D) and individual demographic and laboratory characteristics. Since the increasing trend of C-reactive protein (CRP) inversely correlated with the classification of CYP2C19 gene polymorphisms, it was suggested that the inflammation counteracted the trend of Ct according to CYP2C19 gene polymorphisms. Spearman’s rank-order correlation analysis showed significant correlations between Ct and dose per body weight, CRP, and α1-acid glycoprotein (α1-AGP). Multivariate linear regression analysis showed that age, dose per body weight, CRP, and α1-AGP were significant explanatory factors for Ct. In particular, elevated α1-AGP levels were found to have significant explanatory value for decreased Ct. Although the present study has critical limitations, such as the patient sample was small in size and being limited to a single medical institution, this finding may explain some of the inter-individual variability in plasma VRCZ concentration.
- 29 March 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (5) , 102689
Assessment of incidence and risk factors of COVID-19-associated candidemia using diagnosis procedure combination data
- 29 March 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (5) , 102689
Assessment of incidence and risk factors of COVID-19-associated candidemia using diagnosis procedure combination data
- Open Access
- 7 March 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (3) , 276
Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan
Background: Prescribing antiviral agents for severe acute respiratory syndrome coronavirus 2 requires careful consideration based on the patient’s risk factors for severe disease progression and their vaccination status. However, effective interventions ensuring the appropriate use of antiviral agents by physicians have yet to be fully established. Thus, this study evaluated the impact of an educational film on antiviral prescription rates for coronavirus disease 2019 (COVID-19). Methods: This prospective, nationwide, web-based survey enrolled 1500 physicians. They were instructed to view a short educational film and assess the necessity of prescribing antiviral agents in 16 fictitious scenarios featuring adult patients with COVID-19 with varying risk factors for severe disease and vaccination statuses. We compared the antiviral prescription rates before and after viewing the educational film. Results: There was a significant increase in the antiviral prescription rates after viewing the educational film, particularly nirmatrelvir/ritonavir prescribed in cases involving immunocompromised patients (from 31.3% to 49.4%) and those with obesity (from 15.1% to 33.7%) who were unvaccinated and had no risk of drug interactions. However, viewing the educational film made little to no impact on the prescription rates for the patients with hypertension and hyperlipidemia or those with no underlying conditions. Conclusions: Short educational films may promote the appropriate use of antiviral agents for COVID-19. However, their impact on altering prescription behavior appears limited and varies according to the clinical context.
- 7 March 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (3) , 276
Open AccessInfluence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan
Background: Prescribing antiviral agents for severe acute respiratory syndrome coronavirus 2 requires careful consideration based on the patient’s risk factors for severe disease progression and their vaccination status. However, effective interventions ensuring the appropriate use of antiviral agents by physicians have yet to be fully established. Thus, this study evaluated the impact of an educational film on antiviral prescription rates for coronavirus disease 2019 (COVID-19). Methods: This prospective, nationwide, web-based survey enrolled 1500 physicians. They were instructed to view a short educational film and assess the necessity of prescribing antiviral agents in 16 fictitious scenarios featuring adult patients with COVID-19 with varying risk factors for severe disease and vaccination statuses. We compared the antiviral prescription rates before and after viewing the educational film. Results: There was a significant increase in the antiviral prescription rates after viewing the educational film, particularly nirmatrelvir/ritonavir prescribed in cases involving immunocompromised patients (from 31.3% to 49.4%) and those with obesity (from 15.1% to 33.7%) who were unvaccinated and had no risk of drug interactions. However, viewing the educational film made little to no impact on the prescription rates for the patients with hypertension and hyperlipidemia or those with no underlying conditions. Conclusions: Short educational films may promote the appropriate use of antiviral agents for COVID-19. However, their impact on altering prescription behavior appears limited and varies according to the clinical context.
- Open Access
Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies.
Open AccessCross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination
Background: Current influenza A vaccines primarily induce neutralizing antibodies targeting the variable hemagglutinin (HA) head domain, limiting their effectiveness against diverse or emerging influenza A virus (IAV) subtypes. The conserved HA stem domain, particularly the long α-helix (LAH) epitope, is a focus of universal vaccine research due to its cross-protective potential. Additionally, Fc-mediated functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) are recognized as important protective immune mechanisms. This study evaluated IgG responses to the HA head, stem, and LAH regions and assessed cross-reactive potential through neutralization, ADCC, and ADCP assays. Methods: IgG responses to the HA head, stem, and LAH regions were measured in vaccinated individuals. Functional assays were conducted for neutralization, ADCC, and ADCP to evaluate the association between antibody levels and immune function. Results: The results showed that HA head-specific IgG increased significantly after vaccination in 50 individuals, whereas stem-specific IgG increased by 72% and LAH-specific IgG by 12–14%. Among the induced antibody subclasses, IgG1 was predominantly increased. Neutralization titers were detected in viruses of the same strain as the vaccine strain, but not in classical or pandemic strains (H5N1, H7N9). HA stem-specific IgG1 antibody titers showed a significant correlation with ADCC/ADCP activity breadth, but no correlation was observed with neutralization breadth. Conclusions: These findings suggest that although current influenza vaccines can induce HA stem-targeted cross-reactive antibodies, their quantity may be insufficient for broad cross-protection, underscoring the need for improved vaccine strategies.